Current Edition

News

CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders

New categories launched with awards for Accelerating Innovation, Start-ups and being at the Heart of Pharma The 20th-anniversary edition of the CPHI Pharma Awards is now open for entries, with …

Continue Reading →
News

Novartis, Biogen walk on Sangamo partnerships

Novartis and Biogen both walked away from separate neurodegenerative deals with Sangamo Therapeutics, leaving the California-based genomic medicine company scrambling to assess its options. Novartis was the first to …

Continue Reading →
News

Vitestro raises vital funding for autonomous blood drawing device

The company raises €12m in financing with a view to entering the European market. Vitestro – a company that has developed autonomous blood drawing technology …

Continue Reading →
News

Astellas and Pfizer reveal positive results for Xtandi

Research data follow the phase 3 EMBARK trial and involves men with non-metastatic prostate cancer. Astellas has announced positive results from its phase 3 EMBARK …

Continue Reading →
News

AstraZeneca and MSD’s Lynparza get a green light

Combination therapy treats patients with metastatic castration-resistant prostate cancer. AstraZeneca and MSD have announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted …

Continue Reading →
News

L.B. Bohle Presents Innovations at Interpack

Landing page whets visitors’ appetite for the trade fair The Interpack, the leading trade fair for the packaging and pharmaceutical industry, will open its doors …

Continue Reading →
News

Nemera and Nelson Labs Europe strengthen partnership to offer integrated services to customers

This strategic alliance will give a unique advantage to pharmaceutical & biotech customers – accelerating the go-to-market of their drug-device combination products by offering analytical …

Continue Reading →
News

Immutep reveals initiation of pivotal Efti study

The clinical trial also involves paclitaxel in the treatment of metastatic breast cancer. Immutep – a company that concentrates on developing novel LAG-3 immunotherapies for …

Continue Reading →
News

Acesion announces positive atrial fibrillation study

Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a normal sinus rhythm. Acesion Pharma – a company focused on novel therapies …

Continue Reading →
News

Vygon monitors provide improvement for ovarian cancer patients

Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019. The complex procedure, Cytoreductive Surgery (CRS), is being directed by a …

Continue Reading →